• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of MS4A4A function in rheumatoid arthritis pathogenesis and establishment of basic information for new treatment methods

Research Project

Project/Area Number 21K08446
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 54020:Connective tissue disease and allergy-related
Research InstitutionKitasato University

Principal Investigator

Yamaoka Kunihiro  北里大学, 医学部, 教授 (20425317)

Co-Investigator(Kenkyū-buntansha) 松枝 佑  北里大学, 医学部, 助教 (00623208)
有沼 良幸  北里大学, 医学部, 講師 (30527437)
Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2023: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2022: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2021: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
KeywordsMS4A4A単球 / 関節リウマチ / MS4A4A / 単球 / 破骨細胞 / マクロファージ
Outline of Research at the Start

関節リウマチ(RA)の治療は十分な効果が得られない患者が3~6割、投薬不要な状態に至ることは無いに等しい。我々は、RA患者末梢血での遺伝子発現解析により疾患活動性と相関する遺伝子群を同定し、機能未知の分子MS4A4Aを同定した。MS4A4Aは末梢血単球サブセットで高発現することから、単球系細胞での機能解析とRA病態との関与を明らかにする目的にMS4A4Afloxマウスを作成した。本研究課題では単球系細胞特異的MS4A4AコンディショナルKOマウスを作成し、RA病態への関与について明らかにすることを目的とする。

Outline of Final Research Achievements

Peripheral blood mononuclear cells were collected from patients with rheumatoid arthritis, and MS4A4A expression was analyzed. MS4A4A expression was found only in monocytes and was specifically elevated in rheumatoid arthritis patients. The three monocyte subset fractions all showed significantly higher expression levels, in rheumatoid arthritis patients compared to the other two groups. No correlation with disease activity, which had been observed in previous studies, was found. However, a correlation between serum IL-4 and IFN-γ was observed, suggesting a relationship with the pathophysiology. The correlation with disease activity was partly due to the cross-sectional nature of the study.

Academic Significance and Societal Importance of the Research Achievements

本研究は関節リウマチの疾患活動性と相関して発現が誘導される遺伝子MS4a4aに着目し、その生体内における役割と関節リウマチ病態への関わりを明らかにすることを目的としている。ヒトとマウスからの検体を用いることで疾患特異性を証明し、MS4a4a発現を治療または疾患活動性マーカーとしての可能性を検証する。未だ治癒させることが困難である関節リウマチにおける新たな阻害標的、または未だ主観的評価に頼る疾患活動性をより客観的に評価することを可能とする研究であり、社会的意義は大きいと考えられる。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (62 results)

All 2023 2022 2021

All Journal Article (24 results) (of which Int'l Joint Research: 9 results,  Peer Reviewed: 24 results,  Open Access: 22 results) Presentation (33 results) (of which Int'l Joint Research: 4 results,  Invited: 11 results) Book (5 results)

  • [Journal Article] Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication2023

    • Author(s)
      Kameda H., Yamaoka K., Yamanishi Y., Tada M., Koike R., Nakajima A., Fusama M., Fujii T
    • Journal Title

      Mod Rheumatol .

      Volume: 34(1) Issue: 1 Pages: 1-10

    • DOI

      10.1093/mr/road098

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan2023

    • Author(s)
      Tanaka Y., Nakayamada S., Yamaoka K., Ohmura K., Yasuda S.
    • Journal Title

      Modern Rheumatol

      Volume: 33(1) Issue: 1 Pages: 211-153

    • DOI

      10.1093/mr/roac007

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis2023

    • Author(s)
      Charles‐Schoeman C., Choy E., McInnes IB., Mysler E., Nash P., Yamaoka K., Lippe R., Khan N., Shmagel, AK., Palac H., Suboticki J., Curtis JR.
    • Journal Title

      RMD Open

      Volume: 9(4) Issue: 4 Pages: e003392-e003392

    • DOI

      10.1136/rmdopen-2023-003392

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Real-world efficacy of belimumab in achieving remission or low-disease activity in systemic lupus erythematosus: A retrospective study2023

    • Author(s)
      Hasegawa Y., Arinuma Y., Asakura H., Shindo R., Ino K., Kanayama Y., Tanaka T., Matsueda Y., Wada T., Oku K., Yamaoka K.
    • Journal Title

      Mod Rheumatol.

      Volume: - Issue: 4 Pages: 732-740

    • DOI

      10.1093/mr/road078

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study.2023

    • Author(s)
      Kubo S., Miyazaki Y., Amano K., Matsui K., Kameda H., Inoue Y., Nakayamada S., Ogura T., Kaneko Y., Yamaoka K., Tanaka Y
    • Journal Title

      RMD Open

      Volume: 9(2) Issue: 2 Pages: e003029-e003029

    • DOI

      10.1136/rmdopen-2023-003029

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme2023

    • Author(s)
      Fleischmann R., Curtis JR., Schoeman CC., Mysler E., Yamaoka K., Richez C., Palac H., Dilley D., Liu J., Strengholt S
    • Journal Title

      Ann Rheum Dis

      Volume: 82(9) Issue: 9 Pages: 1130-1141

    • DOI

      10.1136/ard-2023-223916

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Involvement of the complement system in immune thrombocytopenia: review of the literature2023

    • Author(s)
      Shindo R., Abe R., Oku K., Tanaka T., Matsueda., Wada T., Arinuma Y., Tanaka S., Ikenoue T., Miyakawa Y., Yamaoka K
    • Journal Title

      Immunol Med

      Volume: 46(4) Issue: 4 Pages: 182-190

    • DOI

      10.1080/25785826.2023.2213976

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial2023

    • Author(s)
      Wada t., Hibino M., Yamaoka K,.et al.
    • Journal Title

      Front Med (Lausanne)

      Volume: 10:1139046

    • DOI

      10.3389/fmed.2023.1139046

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] JAK inhibitors in rheumatology2023

    • Author(s)
      Yamaoka Kunihiro、Oku Kenji
    • Journal Title

      Immunological Medicine

      Volume: online ahead Issue: 3 Pages: 1-10

    • DOI

      10.1080/25785826.2023.2172808

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Investigation of the poor prognostic factors for life and functional prognosis in patients with asymptomatic dermatomyositis2023

    • Author(s)
      Kondo J, Oku K., Hasegwa Y., Muramatsu T., Matsueda Y., Arinuma Y., Yamaoka K.
    • Journal Title

      Kitasato Med J.

      Volume: 53 Pages: 21-28

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Varied risk of developing herpes zoster among molecular targeting therapy in rheumatoid arthritis patients: a single-center study.2023

    • Author(s)
      Muramatsu T., Oku K., Ikenoue T., Kondo J., Hasegawa Y., Matsueda Y., Arinuma Y., Yamaoka, K
    • Journal Title

      Kitasato Med J

      Volume: 53 Pages: 10-20

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The pathogenic role of lupus-specific autoantibodies and Interleukin-6 on demyelination of the brainstem and spinal cord in systemic lupus erythematosus2023

    • Author(s)
      Hasegawa Yasuhiro、Arinuma Yoshiyuki、Muramatsu Takumi、Kondou Junichi、Matsueda Yu、Kanayama Yoshiro、Ino Kazuma、Tanaka Tomoki、Wada Tatsuhiko、Oku Kenji、Yamaoka Kunihiro
    • Journal Title

      Lupus

      Volume: 32 Issue: 3 Pages: 401-410

    • DOI

      10.1177/09612033231151600

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial2023

    • Author(s)
      Curtis JR., Yamaoka K., Chen Y-H., Bhatt DL., Gunay LM., Sugiyama N., Connell CA., Wang C., Wu J., Menon S., Vranic I.,
    • Journal Title

      Ann Rheum Dis

      Volume: 82(3) Issue: 3 Pages: 331-343

    • DOI

      10.1136/ard-2022-222543

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Clinical and immunological effects of hydroxychloroquine in patients with active rheumatoid arthritis despite antirheumatic treatment2022

    • Author(s)
      Takei H, Takanashi S, Otomo K, Hanaoka H, Kikuchi J, Yamaoka K, Yoshimoto K, Abe T, Takeuchi T, Kaneko Y.
    • Journal Title

      Mod Rheumatol.

      Volume: - Issue: 1 Pages: 50-59

    • DOI

      10.1093/mr/roac153

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results2022

    • Author(s)
      Tanaka Yoshiya、Matsubara Tsukasa、Tsutomu Takeuchi, et al.
    • Journal Title

      Modern Rheumatology

      Volume: ー Issue: 4 Pages: 668-679

    • DOI

      10.1093/mr/roac084

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Serum cytokines and bone metabolic markers in patients with rheumatoid arthritis treated with biological disease modifying anti-rheumatic drugs2022

    • Author(s)
      Tamai Hiroya、Nishina Naoshi、Kikuchi Jun、Izumi Keisuke、Otomo Kotaro、Yoshimoto Keiko、Yamaoka Kunihiro、Takeuchi Tsutomu、Kaneko Yuko
    • Journal Title

      Clinical Rheumatology

      Volume: 42 Issue: 3 Pages: 721-730

    • DOI

      10.1007/s10067-022-06390-x

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Correlation between soluble TREM2 and anti-GluN2 antibody in lupus patients with diffuse psychiatric and neuropsychological syndromes2022

    • Author(s)
      Arinuma Yoshiyuki、Hasegawa Yasuhiro、Tanaka Tomoki、Matsueda Yu、Wada Tatsuhiko、Oku Kenji、Yamaoka Kunihiro
    • Journal Title

      Rheumatology

      Volume: 62 Issue: 4 Pages: e105-e106

    • DOI

      10.1093/rheumatology/keac488

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years2022

    • Author(s)
      Ishiguro Naoki、Tanaka Yoshiya、Matsubara Tsukasa、Atsumi Tatsuya、Amano Koichi、Sugiyama Eiji、Yamaoka Kunihiro、Winthrop Kevin、Kivitz Alan、Burmester Gerd R、Gottenberg Jacques-Eric、Genovese Mark C、Matzkies Franziska、Guo Ying、Jiang Deyuan、Takeuchi Tsutomu
    • Journal Title

      Modern Rheumatology

      Volume: 33 Issue: 1 Pages: 64-72

    • DOI

      10.1093/mr/roac020

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naive to MTX treatment (FINCH 3)2022

    • Author(s)
      Atsumi Tatsuya、Tanaka Yoshiya、Matsubara Tsukasa、Amano Koichi、Ishiguro Naoki、Sugiyama Eiji、Yamaoka Kunihiro、Westhovens Ren、Ching Daniel W T、Messina Osvaldo Daniel、Burmester Gerd R、Genovese Mark、Bartok Beatrix、Pechonkina Alena、Kondo Akira、Yin Zhaoyu、Gong Qi、Tasset Chantal、Takeuchi Tsutomu
    • Journal Title

      Modern Rheumatology

      Volume: ー Issue: 4 Pages: 657-667

    • DOI

      10.1093/mr/roac083

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials.2022

    • Author(s)
      Winthrop KL., Nash P., Yamaoka K., Mysler E., Khan N., Camp K L., Song Y., Suboticki J L., Curtis J R .
    • Journal Title

      Annals of the Rheumatic Diseases

      Volume: 81(2): Issue: 2 Pages: 206-213

    • DOI

      10.1136/annrheumdis-2021-220822

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Clinical management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis receiving tofacitinib treatment.2022

    • Author(s)
      Winthrop KL., Curtis JR., Yamaoka K., Lee EB. ,Hirose T., Rivas JL., Kwok K., Burmester GR.
    • Journal Title

      Rheumatology and Therapy

      Volume: 9(1) Issue: 1 Pages: 243-263

    • DOI

      10.1007/s40744-021-00390-0

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE).2021

    • Author(s)
      Kameda H, Takeuchi T, Yamaoka K, Oribe M, Kawano M, Yokoyama M, Pangan A, Konishi Y, Meerwein S,Tanaka Y.
    • Journal Title

      Arthritis Research & Therapy

      Volume: 23(1):9 Issue: 1 Pages: 1-10

    • DOI

      10.1186/s13075-020-02387-6

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Thymus variants on imaging in patients with rheumatoid arthritis-Clinical and immunological significance.2021

    • Author(s)
      Murata O., Suzuki K., Takeuchi T., Sugiura H., Kondo Y., Takeshita M., Koga K., Takiguchi M., Kassai Y., Yasuoka H., Yamaoka K., Morita R., Yoshimura A.
    • Journal Title

      Rheumatology(Oxford)

      Volume: 60(12) Issue: 12 Pages: 5595-5600

    • DOI

      10.1093/rheumatology/keab164

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] A Case of Anti-MDA5 Antibody-positive Dermatomyositis Developing Reversible Cerebral Vasospasm Syndrome Successfully Treated by Multi-Immunosuppressant Combination Including Mycophenolate Mofetil.2021

    • Author(s)
      Muramatsu T, Tono T, Kanayama Y, Hasegawa Y, Kondo J, Hoshiyama T, Wada T, Arinuma Y, Tanaka S, Yamaoka K.
    • Journal Title

      Modern Rheumatology Case Reports

      Volume: 5 (1) Issue: 1 Pages: 69-75

    • DOI

      10.1080/24725625.2020.1810398

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] MTX皮下注射製剤を含めたMTXの用法・用量2023

    • Author(s)
      山岡 邦宏
    • Organizer
      第67回日本リウマチ学会総会・学術集会 シンポジウム
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] 分子標的治療薬を用いたD2TRA治療2023

    • Author(s)
      山岡 邦宏
    • Organizer
      第67回日本リウマチ学会総会・学術集会 シンポジウム
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] Finding the right treatment for the right patient: what similarities and key differences among RA, PsA and axSpA determine treatment decisions,2023

    • Author(s)
      Yamaoka K
    • Organizer
      European congress of Pheumatology(EULAR 2023)
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] 関節リウマチ治療におけるtsDMARDsの課題に向けた取り組み2023

    • Author(s)
      山岡 邦宏
    • Organizer
      第38回日本臨床リウマチ学会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] 帯状疱疹ワクチンの既存情報からリウマチ膠原病患者での接種方法を考える2023

    • Author(s)
      山岡 邦宏
    • Organizer
      第38回日本臨床リウマチ学会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] 最新エビデンスから紐解く関節リウマチ治療~JAK阻害薬のベネフィット・リスク~2023

    • Author(s)
      山岡 邦宏
    • Organizer
      第8回日本骨免疫学会学術集会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] 関節リウマチの骨破壊病態に対する分子標的治療薬の作用と臨床的効果2023

    • Author(s)
      山岡 邦宏
    • Organizer
      第7回日本骨免疫学会冬期学術集会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] Decreased peripheral monocyte and neutrophil count associate with drug persistency in rheumatoid arthritis patients treated with a Janus kinase inhibitor.2023

    • Author(s)
      Shishido E,. Matsueda Y,. Yamaoka K.et al
    • Organizer
      25rd The Asia Pacific League of Associations for Rheumatology(APLAR)
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] べリムマブ投与後に不安症状を呈した全身性エリテマトーデスの1例における髄液IL-6と抗MMDA受容体サブユニットGluN2抗体の変化2023

    • Author(s)
      有沼 良幸、奥 健志、山岡 邦宏.
    • Organizer
      第51回日本臨床免疫学会総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 抗Sm抗体はMMP-2を介してClaudin-5の分解を促進しカプトプリルにより回復する2023

    • Author(s)
      有沼 良幸、奥 健志、山岡 邦宏
    • Organizer
      第51回日本臨床免疫学会総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 分子の基礎的解析から治療薬へ、そしてその先へ2023

    • Author(s)
      山岡 邦宏
    • Organizer
      日本臨床免疫学会・第4回免疫疾患横断セミナー
    • Related Report
      2023 Annual Research Report
  • [Presentation] Two-Year Outcome of Belimumab Therapy in Patients with Systemic Lupus Erythematosus.2023

    • Author(s)
      AsakuraH, Hasegawa Y, Arinuma Y, Tsugita N, Ikeda K, Iwadate Y, Shimode K, Tanaka T, Matsueda Y, Wada T, Tanaka S, Oku K, Yamaoka K.
    • Organizer
      第67回日本リウマチ学会総会・学術集会.
    • Related Report
      2023 Annual Research Report
  • [Presentation] Effect of Belimumab on Patient-Reported Outcomes in patients with systemic lupus erythematosus.2023

    • Author(s)
      Hasegawa Y, Arinuma Y, Oku K, Yamaoka K.
    • Organizer
      第67回日本リウマチ学会総会・学術集会.
    • Related Report
      2023 Annual Research Report
  • [Presentation] Investigation of poor prognostic factors in patients with asymptomatic dermatomyositis2023

    • Author(s)
      Kondo J, Oku K, Matseda Y, Hasegawa Y, Muramatsu T, Kanayama Y, Ino K, Shindo R, Arinuma Y, Yamaoka K.
    • Organizer
      第67回日本リウマチ学会総会・学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] MS4A4A expression in peripheral blood monocytes of patients with rheumatoid arthritis.2023

    • Author(s)
      Muramatsu T, Oku K, Matsueda Y, Kondo J, Hasegawa Y, Yamaoka K.
    • Organizer
      第67回日本リウマチ学会総会・学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 関節リウマチに対する分子標的治療の安全性と課題.2023

    • Author(s)
      山岡 邦宏
    • Organizer
      第31回日本医学会総会学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] べリムマブ投与後に不安症状を呈した全身性エリテマトーデスの1例における髄液IL-6と抗NMDA受容体サブユニットGluN2抗体の変化.2023

    • Author(s)
      有沼 良幸、下出 公介、進藤 理沙、長谷川 靖浩、田中 知樹、松枝 佑、和田 達彦、奥 健志、山岡 邦宏.
    • Organizer
      第67回日本リウマチ学会総会・学術集会.
    • Related Report
      2023 Annual Research Report
  • [Presentation] csDMARDで効果不十分な日本人関節リウマチ(RA) 患者におけるウパダシニブ(UPA)の有効性及び安全性:SELECT-SUNRISE試験5年間の結果.2023

    • Author(s)
      亀田 秀人、竹内 勤、山岡 邦宏、織部 元廣、川野 光弘、横山 雅行、小西 裕子、長南 寿実、Penn SK, Camp HS、 田中 良哉.
    • Organizer
      第67回日本リウマチ学会総会・学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 膠原病に伴う慢性血栓塞栓性肺高血圧症の臨床的特徴の検討.2023

    • Author(s)
      下手 公介、松枝 佑、次田 奈央、池田 慶介、岩楯 洋祐、朝倉 啓友、田中 知樹、和田 達彦、有沼 良幸、奥 健志、田中 住明、山岡 邦宏.
    • Organizer
      第67回日本リウマチ学会総会・学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 日本人関節リウマチ患者におけるヒドロキシクロロキンの有効性、安全性の検討.2023

    • Author(s)
      武井 裕史、高梨 敏史、大友 耕太郎、花岡 洋成、菊池 潤、山岡 邦宏、吉本 桂子、竹内 勤、金子 祐子.
    • Organizer
      第67回日本リウマチ学会総会・学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 当院における膠原病疾患合併間質性肺疾患(CTD-ILD)に対するnintedanib治療の実際.2023

    • Author(s)
      池田 慶介、田中 知樹、次田 奈央、岩楯 洋祐、朝倉 啓友、下手 公介、松枝 佑、有沼 良幸、和田 達彦、奥 健志、田中 住明、山岡 邦宏
    • Organizer
      第67回日本リウマチ学会総会・学術集会.
    • Related Report
      2023 Annual Research Report
  • [Presentation] ANCA関連血管炎の寛解維持におけるリツキシマブ治療の効果.2023

    • Author(s)
      岩楯 洋祐、奥 健志、池田 慶介、木下 奈々、京田 俊介、阪本 陽介、宍戸 瑛理、朝倉 啓友、田中 知樹、松枝 佑、和田 達彦、有沼 良幸、田中 住明、山岡 邦宏.
    • Organizer
      第67回日本リウマチ学会総会・学術集会.
    • Related Report
      2023 Annual Research Report
  • [Presentation] Non-HIV ニューモシスチス肺炎(PCP)に続発した慢性呼吸窮迫症候群(ARDS)対しトシリズマブ(TCZ)が有効であった関節リウマチ(RA)の一例.2023

    • Author(s)
      次田 奈央、和田 達彦、池田 慶介、岩楯 洋祐、朝倉 啓友、下手 公介、田中 知樹、松枝 佑、有沼 良幸、奥 健志、田中 住明、山岡 邦宏.
    • Organizer
      第67回日本リウマチ学会総会・学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 関節リウマチ患者に対する生物学的製剤導入クリニカルパス入院の患者満足度調査結果と感染症による入院の予防効果の検証.2023

    • Author(s)
      中村 絵美里、井下 千葉美、西川 美紀、東野 俊洋、田中 知樹、山岡 邦宏.
    • Organizer
      第67回日本リウマチ学会総会・学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] JAK阻害第一次無効により他のb/tsDMARDへスイッチを行った関節リウマチ患者尾予後.2023

    • Author(s)
      尾方 優香、村松 匠、有沼 良幸、奥 健志、山岡 邦宏
    • Organizer
      第67回日本リウマチ学会総会・学術集会.
    • Related Report
      2023 Annual Research Report
  • [Presentation] 初発全身性エリテマトーデス患者におけるヒドロキシクロロキン単剤療法の有効性と関連する臨床的因子の検討.2023

    • Author(s)
      田中 宏昌、長谷川 靖浩、有沼 良幸、奥 健志、山岡 邦宏.
    • Organizer
      第67回日本リウマチ学会総会・学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 42.見戸幸子、野中美和、中川智枝、 渡辺 理彦、小寺良夫、熊谷雄治、山岡邦宏.2023

    • Author(s)
      SARS-CoV-2ウイルス解明が進み、新規情報が更新される中での COVID-19を対象とした多施設共同医師主導試験における調整事務局オペレーションの報告
    • Organizer
      第14回日本臨床試験学会学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] expression in peripheral blood monocytes of patients with rheumatoid arthritis.2023

    • Author(s)
      村松匠、奥 健志、松枝 佑、近藤 惇一、長谷川 靖浩、山岡 邦宏.
    • Organizer
      第67回日本リウマチ学会
    • Related Report
      2022 Research-status Report
  • [Presentation] Treatment goals, targets and guidelines in lupus nephritis2021

    • Author(s)
      Yamaoka K
    • Organizer
      23nd Asia-Pacific League of Associations for Rhuematology Congress
    • Related Report
      2021 Research-status Report
    • Int'l Joint Research / Invited
  • [Presentation] Considering the efficacy of tofacitinibthrough recent information on safety.2021

    • Author(s)
      Yamaoka K
    • Organizer
      23nd Asia-Pacific League of Associations for Rhuematology Congress
    • Related Report
      2021 Research-status Report
    • Int'l Joint Research / Invited
  • [Presentation] 関節リウマチの新規治療2021

    • Author(s)
      山岡 邦宏
    • Organizer
      第36回 日本臨床リウマチ学会
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] 乾癬性関節炎患者におけるウパダシニブの安全性:全体集団及び日本人集団における臨床試験併合解析の結果(Safety Profile of Upadacitinib in Psoriatic Arthritis (PsA): Findings in the Global Population and Japanese Subgroup From a Pooled Analysis of 2 Phase 3 Clinical Trials.)2021

    • Author(s)
      Yamaoka K., Burmester GR., Winthrop K., Nash P. Goupille P., Azevedo VF., Salvarani C., Mccaskill RM., Liu J, Pierre-Louis BJ., Anderson JK., Ruderman EM.
    • Organizer
      第65回日本リウマチ学会総会・学術集会.
    • Related Report
      2021 Research-status Report
  • [Presentation] JAKと生物製剤による関節破壊治療の最前線  Front-line treatments forthe joint destructive disease; JAK inhibitors andbiologics2021

    • Author(s)
      山岡 邦宏.
    • Organizer
      第42回炎症・再生医学会
    • Related Report
      2021 Research-status Report
    • Invited
  • [Book] 関節リウマチ治療 実践バイブル 改訂第2版2021

    • Author(s)
      山岡 邦宏
    • Publisher
      南江堂
    • Related Report
      2021 Research-status Report
  • [Book] 内科学2021

    • Author(s)
      山岡 邦宏
    • Publisher
      朝倉書店
    • Related Report
      2021 Research-status Report
  • [Book] 今日の治療指針2022年版2021

    • Author(s)
      山岡 邦宏
    • Publisher
      医学書院
    • Related Report
      2021 Research-status Report
  • [Book] 関節リウマチ薬はこう使う!2021

    • Author(s)
      山岡 邦宏
    • Publisher
      月刊薬事 じほう
    • Related Report
      2021 Research-status Report
  • [Book] 関節リウマチ治療 実践バイブル 改訂第2版2021

    • Author(s)
      有沼 良幸, 山岡 邦宏
    • Publisher
      南江堂
    • Related Report
      2021 Research-status Report

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi